FC
Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
---|---|---|---|---|---|---|---|
Structural basis of the activation of the CC chemokine receptor 5 by a chemokine agonist | Science advances | 2021 | 166 | 101 | |||
CCR5 tyrosine sulfation heterogeneity generates cell surface receptor subpopulations with different ligand binding properties | Biochimica et Biophysica Acta - General Subjects | 2020 | 218 | 154 | |||
Rapid and low-cost multiplex synthesis of chemokine analogs | Journal of Biological Chemistry | 2018 | 353 | 1 | |||
Stability of 5P12-RANTES, A Candidate Rectal Microbicide, in Human Rectal Lavage | AIDS Research and Human Retroviruses | 2017 | 337 | 0 | |||
Generating Chemokine Analogs with Enhanced Pharmacological Properties Using Phage Display | Methods in enzymology | 2016 | 512 | 5 | |||
A scalable low-cost cGMP process for clinical grade production of the HIV inhibitor 5P12-RANTES in Pichia pastoris | Protein expression and purification | 2016 | 481 | 221 | |||
Enhancing Antitumor Immune Responses by Optimized Combinations of Cell-penetrating Peptide-based Vaccines and Adjuvants | Molecular therapy | 2016 | 599 | 236 | |||
The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease? | PloS one | 2015 | 497 | 264 | |||
Efficient orthogonal bioconjugation of dendrimers for synthesis of bioactive nanoparticles | Bioconjugate chemistry | 2011 | 591 | 0 | |||
Chemokine analogues show suitable stability for development as microbicides | Journal of acquired immune deficiency syndromes | 2008 | 551 | 0 | |||
Highly potent HIV inhibition: engineering a key anti-HIV structure from PSC-RANTES into MIP-1 beta/CCL4 | Protein engineering, design & selection | 2008 | 603 | 8 | |||
Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide | Proceedings of the National Academy of Sciences of the United States of America | 2008 | 535 | 2 | |||
Medicinal chemistry applied to a synthetic protein: development of highly potent HIV entry inhibitors | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 622 | 1 | |||
Human immunodeficiency virus type 1 entry inhibitors selected on living cells from a library of phage chemokines | Journal of virology | 2003 | 479 | 327 |